Searchable abstracts of presentations at key conferences in endocrinology

ea0078OC7.4 | Oral Communications 7 | BSPED2021

Patient experiences of the changes made to the Cardiff and Vale University Health Board Paediatric Diabetes service due to COVID-19

Bone Megan , Pryce Rebekah

Background: Children and Young People (CYP) with diabetes are encouraged to attend four clinics each year.(1,2) During the COVID-19 pandemic, concerns regarding risk of virus transmission, reduced staff numbers and social distancing requirements, meant the Cardiff and Vale University Health Board (CAVUHB) paediatric diabetes service had to find alternative ways to communicate with patients. This included video consultations and drive-through HbA1c clinics as a substitute for s...

ea0078p27 | Diabetes | BSPED2021

The physical and psychological impact of the COVID-19 pandemic on children and young people with diabetes

Bone Megan , Pryce Rebekah , Murphy Rhian

Background: During the pandemic, children and young people (CYP) have been in social isolation and faced many changes to their normal routine. Limited research has been done to understand how CYP with diabetes have been affected.Objective: The objective of this study was to understand how CYP with diabetes have been affected by the COVID-19 pandemic.Methods: Questionnaires were produced which included both quantitative and qualitat...

ea0007p43 | Diabetes, metabolism and cardiovascular | BES2004

Improvements in glucose utilisation immediately following exercise in patients with and without type 2 diabetes seem to be independent of improvements in insulin sensitivity

Macdonald A , Harrison M , Bone A , Watt P

Aim: Acute bouts of exercise are known to have a beneficial effect on glucose homeostasis immediately following exercise in people with Type 2 Diabetes. Evidence suggests that this effect is independent of the effects of insulin. In this study we compare recently developed indices of insulin sensitivity derived from the oral glucose tolerance test to determine whether the improvements in glucose homeostasis following physical activity are independent of the effects of insulin....

ea0058oc6.3 | Oral Communications 6 | BSPED2018

Has the reduction in maintenance fluid rates following introduction of 2015 BSPED-recommended diabetic ketoacidosis guidelines impacted on complication rates?

Chinoy Amish , Doughty Ian , Bone Mark , Skae Mars , Murray Philip , Padidela Raja

Introduction: In August 2015, a revision of the BSPED-recommended guideline for the management of diabetic ketoacidosis (DKA) was published. A key difference from the previous guideline was a reduction in maintenance fluid rates, with the aim of reducing the incidence of cerebral oedema. Since implementation of these national guidelines, there have been reports within regional networks of an increased incidence in mild acute renal impairment and hypokalaemia. This retrospectiv...

ea0027p52 | (1) | BSPED2011

Educating children in continuous subcutaneous insulin infusion (CSII) therapy; are we improving diabetes control?

Lee Alice , Campbell Judith , Marshall Marie , Ainsworth Sue , Salisbury Louise , Bone Mark , Doughty Ian , Ehtisham Sarah

Background: Continuous subcutaneous insulin infusion (CSII) is proving superior in reducing HbA1c compared to multiple daily injections (MDI) in both the adult and paediatric populations. This study aims to compare the two methods, and evaluate the importance of education when starting insulin pump therapy in children.Design: Patients who attended a ‘pump school’ provided by the Royal Manchester Children’s Hospital between January 2010 and...

ea0028p38 | Clinical practice/governance and case reports | SFEBES2012

The relationship between Vitamin D and HbA1C in a type 1 diabetic paediatric population

Magee Lucia , Mughal Zulf , Ehtisham Sarah , Marshall Marie , Campbell Judith , Ainsworth Susan , Bone Mark , Doughty Ian , Clayton Peter

Clinical, epidemiological and in-vitro studies have found evidence for an association between Vitamin D and diabetes. Vitamin D receptors are found on pancreatic beta-cells, suggesting they have a role in glycaemic control. Vitamin D analogues inhibit inflammatory cytokines involved in destruction of Beta-cells. This study aimed to assess the relationship between Vitamin D and glycaemic control, as measured by HbA1C, in a Type 1 (T1) diabetic paediatric population. HbA1C value...

ea0027oc5.2 | Oral Communications (RCN CYP Diabetes Session) | BSPED2011

Investigating vitamin D status as a determinant of HbA1C% in type 1 diabetic paediatric population

Magee Lucia , Mughal Zulf , Ehtisham Sarah , Campbell Judith , Ainsworth Susan , Marshall Marie , Bone Mark , Doughty Ian , Clayton Peter

Maintaining glycaemic control within recommended levels is crucial to minimise vascular complications associated with type 1 diabetes (T1D). Vitamin D is recognised as a vascular growth-factor. Detection of its receptors on pancreatic β-cells suggests it may have a role in glycaemic control. This study aimed to assess determinants of HbA1C including the potential influence of vitamin D status in a T1 diabetic paediatric population.Methods: Patients ...

ea0036P43 | (1) | BSPED2014

The effect of the introduction of best practice tariff for paediatric diabetes care on service provision and staffing in the West Midlands

Kershaw Melanie , Atkins Marie , Agwu Chizo , Bone Alison , Brown Sabrina , Brown Jennie , Hinde Frank , McCrea Kathryn , Parakkal Raffeeq , Reynolds Ash , Scanlon John , Salt Gill , Sparkes Paitra , Stirling Heather

Objectives: The Department of Health introduced a Best Practice Tariff (BPT) to finance Paediatric Diabetes Services in England, in response to variation in service provision and outcome. The tariff became mandatory in April 2013 and depends on achievement of 13 quality standards (QS). The West Midlands (WM) Region covers an area of 5020 square miles, where 2700 Children with Diabetes receive care from 15 Hospital Trusts who are members of the Regional Paediatric Diabetes Netw...

ea0063gp15 | Calcium and Bone 1 | ECE2019

Recombinant human parathyroid hormone 1–84 for the treatment of adults with chronic hypoparathyroidism: Six-year safety and efficacy results of the RACE study

Bilezikian John P , Bone Henry , Clarke Bart L , Denham Douglas , Germak John , Lee Hak-Myung , Levine Michael A , Mannstadt Michael , Peacock Munro , Rothman Jeffrey G , Sherry Nicole , Shoback Dolores M , Vokes Tamara J , Warren Mark L , Watts Nelson B

Background: RACE is an open-label study that assessed the long-term safety and efficacy of recombinant human parathyroid hormone 1–84 (rhPTH[1–84]) for the treatment of hypoparathyroidism in adults (ClinicalTrials.gov identifier NCT01297309). Here, we present 6-year safety and efficacy data.Methods: Patients initially received 25 or 50 μg of rhPTH(1–84) subcutaneously, once daily, with stepwise dose adjustments of 25 μg (up or do...

ea0049gp47 | Bone & Calcium Homeostasis 2 | ECE2017

Recombinant human parathyroid hormone (rhPTH[1-84], parathyroid hormone rDNA) improves hypercalciuria in patients with hypoparathyroidism: 3-year analysis from RACE study

Clarke Bart L , Vokes Tamara J , Bilezikian John P , Bone Henry G , Denham Douglas S , Lee Hak-Myung , Levine Michael A , Mannstadt Michael , Peacock Munro , Rothman Jeffrey G , Shoback Dolores M , Warren Mark L , Watts Nelson B , Krasner Alan

Hypoparathyroidism (HPT) is characterised by hypocalcaemia and impaired renal phosphate excretion and calcium conservation. Oral calcium supplements and calcitriol can improve serum calcium levels but lack the physiologic effects of PTH on renal reabsorption of calcium. RACE is an ongoing open-label study evaluating the long-term safety of recombinant human parathyroid hormone 1-84 (rhPTH[1-84], parathyroid hormone rDNA) in adults with HPT (NCT01297309). In this interim analys...